A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Local Administration of EXPAREL for Postsurgical Analgesia in Pediatric Subjects 12 to Less Than 17 Years of Age
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 18 Mar 2019 Status changed from recruiting to completed.
- 18 Jan 2019 Planned End Date changed from 30 Sep 2018 to 28 Feb 2019.
- 18 Jan 2019 Planned primary completion date changed from 30 Aug 2018 to 7 Feb 2019.